Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Sphingosine-1-phosphate initiates rapid retraction of pseudopodia by localized RhoA activation.

Koh E, Clair T, Hermansen R, Bandle RW, Schiffmann E, Roberts DD, Stracke ML.

Cell Signal. 2007 Jun;19(6):1328-38. Epub 2007 Jan 19.

PMID:
17307336
2.

L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin.

Clair T, Koh E, Ptaszynska M, Bandle RW, Liotta LA, Schiffmann E, Stracke ML.

Lipids Health Dis. 2005 Feb 28;4:5.

3.

Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation.

Krieg RC, Knuechel R, Schiffmann E, Liotta LA, Petricoin EF 3rd, Herrmann PC.

Proteomics. 2004 Sep;4(9):2789-95.

PMID:
15352252
4.

Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.

Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML.

Cancer Res. 2003 Sep 1;63(17):5446-53.

5.
6.

Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.

Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML.

Cancer Res. 2001 Sep 15;61(18):6938-44.

7.

A sensitive screening assay for secreted motility-stimulating factors.

Nam SW, Clair T, Schiffmann E, Liotta LA, Stracke ML.

Cell Motil Cytoskeleton. 2000 Aug;46(4):279-84.

PMID:
10962482
8.

Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.

Mulvaney PT, Stracke ML, Nam SW, Woodhouse E, O'Keefe M, Clair T, Liotta LA, Khaddurah-Daouk R, Schiffmann E.

Int J Cancer. 1998 Sep 25;78(1):46-52.

9.

Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease.

Lah TT, Babnik J, Schiffmann E, Turk V, Skaleric U.

J Periodontol. 1993 May;64(5 Suppl):485-91. Review.

PMID:
8315571
10.

Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.

Kohn EC, Hollister GH, DiPersio JD, Wahl S, Liotta LA, Schiffmann E.

Int J Cancer. 1993 Apr 1;53(6):968-72.

PMID:
8473054
11.

The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility.

Stracke M, Liotta LA, Schiffmann E.

Symp Soc Exp Biol. 1993;47:197-214.

PMID:
8165565
12.

Cytoskeletal agents inhibit motility and adherence of human tumor cells.

Stracke ML, Soroush M, Liotta LA, Schiffmann E.

Kidney Int. 1993 Jan;43(1):151-7.

13.

Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA.

J Biol Chem. 1992 Feb 5;267(4):2524-9.

14.

A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.

Boike G, Lah T, Sloane BF, Rozhin J, Honn K, Guirguis R, Stracke ML, Liotta LA, Schiffmann E.

Melanoma Res. 1992 Jan-Feb;1(5-6):333-40.

PMID:
1422189
15.
16.

Tumor cell motility.

Liotta LA, Stracke ML, Aznavoorian SA, Beckner ME, Schiffmann E.

Semin Cancer Biol. 1991 Apr;2(2):111-4. Review.

PMID:
1912521
17.

Cell motility, a principal requirement for metastasis.

Stracke ML, Aznavoorian SA, Beckner ME, Liotta LA, Schiffmann E.

EXS. 1991;59:147-62. Review.

PMID:
1833227
18.

Glycolysis as primary energy source in tumor cell chemotaxis.

Beckner ME, Stracke ML, Liotta LA, Schiffmann E.

J Natl Cancer Inst. 1990 Dec 5;82(23):1836-40.

PMID:
2174462
19.
20.

Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.

Aznavoorian S, Stracke ML, Krutzsch H, Schiffmann E, Liotta LA.

J Cell Biol. 1990 Apr;110(4):1427-38.

21.

Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.

Kohn EC, Liotta LA, Schiffmann E.

Biochem Biophys Res Commun. 1990 Jan 30;166(2):757-64.

PMID:
2154219
22.

Motility as a principal requirement for metastasis.

Schiffmann E.

Cancer Invest. 1990;8(6):673-4. No abstract available.

PMID:
2127239
23.

The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells.

Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffmann E.

J Biol Chem. 1989 Dec 25;264(36):21544-9.

24.

Detection of autocrine motility factor in urine as a marker of bladder cancer.

Guirguis R, Schiffmann E, Liu B, Birkbeck D, Engel J, Liotta L.

J Natl Cancer Inst. 1988 Oct 5;80(15):1203-11.

PMID:
3138430
25.

Insulin-like growth factors stimulate chemotaxis in human melanoma cells.

Stracke ML, Kohn EC, Aznavoorian SA, Wilson LL, Salomon D, Krutzsch HC, Liotta LA, Schiffmann E.

Biochem Biophys Res Commun. 1988 Jun 30;153(3):1076-83.

PMID:
3291867
26.

Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection.

Vasanthakumar G, Manjunath R, Mukherjee AB, Warabi H, Schiffmann E.

Biochem Pharmacol. 1988 Feb 1;37(3):389-94.

PMID:
3337740
27.

Tumor autocrine motility factors.

Liotta L, Schiffmann E.

Important Adv Oncol. 1988:17-30. Review. No abstract available.

PMID:
3136075
28.

Tumour motility factors.

Liotta LA, Schiffmann E.

Cancer Surv. 1988;7(4):631-52. Review. No abstract available.

PMID:
3072069
29.

Biochemical mechanisms of tumor invasion and metastases.

Liotta LA, Wewer U, Rao NC, Schiffmann E, Stracke M, Guirguis R, Thorgeirsson U, Muschel R, Sobel M.

Adv Exp Med Biol. 1988;233:161-9. Review.

PMID:
2851925
30.

Biochemical mechanisms of tumor invasion and metastases.

Liotta LA, Wewer U, Rao NC, Schiffmann E, Stracke M, Guirguis R, Thorgeirsson U, Muschel R, Sobel M.

Prog Clin Biol Res. 1988;256:3-16. Review.

PMID:
2835781
31.

Biochemical mechanisms of tumor invasion and metastasis.

Liotta LA, Wewer U, Rao NC, Schiffmann E, Stracke M, Guirguis R, Thorgeirsson U, Muschel R, Sobel M.

Anticancer Drug Des. 1987 Oct;2(2):195-202. Review.

PMID:
2835060
32.

Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration.

Guirguis R, Margulies I, Taraboletti G, Schiffmann E, Liotta L.

Nature. 1987 Sep 17-23;329(6136):261-3.

PMID:
2957596
33.

Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells.

Stracke ML, Guirguis R, Liotta LA, Schiffmann E.

Biochem Biophys Res Commun. 1987 Jul 15;146(1):339-45.

PMID:
3496885
34.

A role for the laminin receptor in leukocyte chemotaxis.

Bryant G, Rao CN, Brentani M, Martins W, Lopes JD, Martin SE, Liotta LA, Schiffmann E.

J Leukoc Biol. 1987 Mar;41(3):220-7.

PMID:
2951468
35.

Regulation of prostaglandin formation by glucocorticoids and their second messenger, lipocortins.

Hirata F, Stracke ML, Schiffmann E.

J Steroid Biochem. 1987;27(4-6):1053-6. Review.

PMID:
2961939
36.

Tumor cell autocrine motility factor.

Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E.

Proc Natl Acad Sci U S A. 1986 May;83(10):3302-6.

37.

Laminin promotes rabbit neutrophil motility and attachment.

Terranova VP, DiFlorio R, Hujanen ES, Lyall RM, Liotta LA, Thorgeirsson U, Siegal GP, Schiffmann E.

J Clin Invest. 1986 Apr;77(4):1180-6.

38.

Tumor autocrine motility factor.

Liotta LA, Guirguis RA, Schiffmann E.

Prog Clin Biol Res. 1986;212:17-24. Review. No abstract available.

PMID:
3086891
39.

Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis.

Ruff M, Schiffmann E, Terranova V, Pert CB.

Clin Immunol Immunopathol. 1985 Dec;37(3):387-96.

PMID:
2414046
40.
41.

Identification and partial characterization of a low-molecular-weight inhibitor of leukotaxis from fibrosarcoma cells.

Warabi H, Venkat K, Geetha V, Liotta LA, Brownstein M, Schiffmann E.

Cancer Res. 1984 Mar;44(3):915-22.

42.

Inhibition of leukocyte chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly.

Hirata F, Notsu Y, Matsuda K, Vasanthakumar G, Schiffmann E, Wong TW, Goldberg AR.

Biochem Biophys Res Commun. 1984 Jan 30;118(2):682-90.

PMID:
6704100
43.

Identification of a bone matrix-derived chemotactic factor.

Somerman M, Hewitt AT, Varner HH, Schiffmann E, Termine J, Reddi AH.

Calcif Tissue Int. 1983 Jul;35(4-5):481-5.

PMID:
6616317
44.

Paradoxical effects of adenosine on neutrophil chemotaxis.

Garcia-Castro I, Mato JM, Vasanthakumar G, Wiesmann WP, Schiffmann E, Chiang PK.

J Biol Chem. 1983 Apr 10;258(7):4345-9.

45.

Inhibitors of endocytosis perturb phospholipid metabolism in rabbit neutrophils and other cells.

Mato JM, Pencev D, Vasanthakumar G, Schiffmann E, Pastan I.

Proc Natl Acad Sci U S A. 1983 Apr;80(7):1929-32.

46.

Adherence and regulation of leukotaxis.

Schiffmann E, Geetha V, Pencev D, Warabi H, Mato J, Hirata F, Brownstein M, Manjunath R, Mukherjee A, Liotta L, Terranova VP.

Agents Actions Suppl. 1983;12:106-20.

PMID:
6573114
47.

Cultured tumor cells produce chemotactic factors specific for endothelial cells: a possible mechanism for tumor-induced angiogenesis.

Seppä ST, Seppä HE, Liotta LA, Glaser BM, Martin GR, Schiffmann E.

Invasion Metastasis. 1983;3(3):139-50.

PMID:
6203869
48.

Enzymatic reduction of oxidized chemotactic peptide N-formyl-L-methionyl-sulfoxide-L-leucyl-L-phenylalanine.

Fliss H, Vasanthakumar G, Schiffmann E, Weissbach H, Brot N.

Biochem Biophys Res Commun. 1982 Nov 16;109(1):194-201. No abstract available.

PMID:
6760863
49.

Regulation of the attachment and migration of bone cells in vitro.

Somerman M, Schiffmann E, Reddi AH, Termine J.

J Periodontal Res. 1982 Sep;17(5):527-9. No abstract available.

PMID:
6218291
50.

Supplemental Content

Loading ...
Support Center